Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of June 3, 2025 in Viatris Inc. Lawsuit
NEW YORK, May 6, 2025 /PRNewswire/ — Levi & Korsinsky, LLP notifies investors in Viatris Inc. ('Viatris' or the 'Company') (NASDAQ: VTRS) of a class action securities lawsuit.
CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Viatris investors who were adversely affected by alleged securities fraud between August 8, 2024 and February 26, 2025. Follow the link below to get more information and be contacted by a member of our team:
https://zlk.com/pslra-1/viatris-inc-lawsuit-submission-form-2?prid=146934&wire=4
VTRS investors may also contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500.
CASE DETAILS: According to the complaint, defendants provided investors with material information concerning the failed inspection of Viatris' Indore, India facility. Defendants' statements misrepresented the FDA's issuance of a warning letter and its impact on Viatris' operations. Defendants routinely referred to the impact of the warning letter as a mere 'minor headwind' for the Company. On February 27, 2025, Viatris announced its financial results for the fourth quarter and full fiscal year 2024 and provided disappointing fiscal 2025 guidance. The Company attributed below-expectation guidance on 'the expected financial impact from Indore facility warning letter and import alert.' Following this news, the price of Viatris' common stock declined dramatically. From a closing market price of $11.24 per share on February 26, 2025, Viatris' stock price fell to $9.53 per share on February 27, 2025, a decline of about 15.21% in the span of just a single day.
WHAT'S NEXT? If you suffered a loss in Viatris during the relevant time frame, you have until June 3, 2025 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.
NO COST TO YOU: If you are a class member, you may be entitled to compensation without payment of any out-of-pocket costs or fees. There is no cost or obligation to participate.
WHY LEVI & KORSINSKY: Over the past 20 years, the team at Levi & Korsinsky has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. Our firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services' Top 50 Report as one of the top securities litigation firms in the United States.
CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
33 Whitehall Street, 17th Floor
New York, NY 10004
jlevi@levikorsinsky.com
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/levi–korsinsky-reminds-shareholders-of-a-lead-plaintiff-deadline-of-june-3-2025-in-viatris-inc-lawsuit–vtrs-302446534.html
SOURCE Levi & Korsinsky, LLP
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Malaysian Reserve
20 hours ago
- Malaysian Reserve
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Iovance Biotherapeutics
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Iovance To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Iovance between August 8, 2024 and May 8, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK, June 10, 2025 /PRNewswire/ — Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Iovance Biotherapeutics, Inc. ('Iovance' or the 'Company') (NASDAQ: IOVA) and reminds investors of the July 14, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions of dollars for investors since its founding in 1995. See As detailed below, the complaint alleges that the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose the true state of Iovance's growth potential; notably, that it was not equipped to generate and drive demand or was otherwise ill equipped to capitalize upon the purported existing demand for its treatments through its network of approved treatment centers. On July 25, 2024, Iovance announced its financial results for the second quarter of fiscal 2024 and reduced its revenue guidance for the full fiscal year 2024. The Company attributed its results and lowered guidance on 1) 'the iCTC completed annual scheduled maintenance in December' and 'capacity was reduced by more than half for about 1 month,' 2) '[l]ower Proleukin sales' than the company expected, and 3) 'the variable pace at which ATCs began treatment patients.' Investors and analysts reacted immediately to Iovance's revelation. The price of Iovance's common stock declined dramatically. From a closing market price of $3.17 per share on May 8, 2025, Iovance's stock price fell to $1.75 per share on May 9, 2025, a decline of about 44.795% in the span of just a single day. The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class who is adequate and typical of class members who directs and oversees the litigation on behalf of the putative class. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. Your ability to share in any recovery is not affected by the decision to serve as a lead plaintiff or not. Faruqi & Faruqi, LLP also encourages anyone with information regarding Iovance's conduct to contact the firm, including whistleblowers, former employees, shareholders and others. To learn more about the Iovance class action, go to or call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). Follow us for updates on LinkedIn, on X, or on Facebook. Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP ( Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.
Malaysian Reserve
21 hours ago
- Malaysian Reserve
Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
LOS ANGELES, June 9, 2025 /PRNewswire/ — The Law Offices of Frank R. Cruz continues its investigation of EchoStar Corporation ('EchoStar' or the 'Company') (NASDAQ: SATS) on behalf of investors concerning the Company's possible violations of federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON ECHOSTAR CORPORATION (SATS), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING A CLAIM TO RECOVER YOUR LOSS. What Is The Investigation About? On May 12, 2025, The Wall Street Journal reported that the Federal Communications Commission had notified EchoStar that it would be investigating the Company's compliance with federal requirements to build a nationwide 5G network. On this news, EchoStar's stock price fell $4.01, or 16.6%, to close at $20.18 per share on May 12, 2025, thereby injuring investors. Then, on May 30, 2025, EchoStar disclosed that it had 'elected not to make an approximately $326 million cash interest payment' in order to 'allow time for the FCC to provide the relief requested in [the Company's] Response' to the FCC's compliance investigation. On this news, EchoStar's stock price fell $2.44, or 12.1%, to close at $17.73 per share on May 30, 2025, thereby injuring investors further. Contact Us To Participate or Learn More: If you purchased EchoStar securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact us: The Law Offices of Frank R. Cruz, 2121 Avenue of the Stars, Suite 800, Century City, California 90067 Call us at: 310-914-5007Email us at: info@ Visit our website at: Follow us for updates on Twitter at If you inquire by email, please include your mailing address, telephone number, and number of shares purchased. This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules. Contact Us:The Law Offices of Frank R. Cruz, Los AngelesFrank R. Cruz310-914-5007fcruz@
Malaysian Reserve
a day ago
- Malaysian Reserve
FINAL NOTICE: Shareholders Have the Right to Lead the BigBear.ai Holdings, Inc. Securities Lawsuit
LOS ANGELES, June 9, 2025 /PRNewswire/ — The DJS Law Group reminds investors of a class action lawsuit against Holdings, Inc. ('BigBear' or 'the Company') (NYSE: BBAI) for violations of the federal securities laws. Shareholders who purchased the Company's securities between March 31, 2022 and March 25, 2025, inclusive (the 'Class Period'), are encouraged to contact the firm before June 10, 2025. CASE DETAILS: The complaint alleges that the Company made false and misleading statements to the market concerning whether BigBear failed to maintain adequate accounting review policies for the disclosure of non-routine and complex transactions. The Company incorrectly believed the conversion option in its 2026 Convertible Notes qualified for a derivative scope exception Accounting Standards Codification ('ASC') 815-40 and failed to comply with ASC 815-15 on the bifurcation of the conversion option. As a result, the Company misstated multiple items in its previously issued financial statements. The Company would be forced to restate its incorrect financial statements If you are a shareholder who suffered a loss, contact us to participate. WHY DJS LAW GROUP? DJS Law Group's primary focus is to enhance investor return through balanced counseling and aggressive advocacy. We specialize in securities class actions, corporate governance litigation, and domestic/international M&A appraisals. Our clients are some of the largest and most sophisticated hedge funds and alternative asset managers in the world. The litigation claims of our clients are extraordinarily valuable assets that demand respect, focus, and results. This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics. CONTACT: David J. Schwartz DJS Law Group 274 White Plains Road, Suite 1 Eastchester, NY 10709 Phone: 914-206-9742 Email: David@
